COMBIZ R. ABDOLRAHIMI, ESQ.
Emerging Technologies & Innovation Leader, Government & Public Services
Main Conference Day Two: Friday, October 18, 2019
The 21st-century global pharmaceutical supply chain is complex, fragmented, and involves multiple parties from countries all over the world. This complexity introduces vulnerabilities that allow the infiltration of substandard/spurious/falsified/falsely-labelled/ counterfeit medicines, now an urgent public health and patient safety problem valued in the billions of dollars. Counterfeit medicines have penetrated all aspects of the drug supply chain including: hospitals, distribution networks, global health programs and unregulated settings like night markets and bodegas.
Discover how to use the shared distributed ledger to make drug supply chains more transparent, accountable and trustworthy.
- Understand why the pharmaceutical supply chain is vulnerable
- Assess what a pharmaceutical block chain could look like
- Evaluate policy and future direction